Zinc Effect on Inflammation and Cardiovascular Risk in HIV

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

August 2, 2024

Study Completion Date

August 2, 2024

Conditions

InflammationCardiovascular DiseasesZinc Deficiency

Interventions

DRUG

Zinc Gluconate

Two 45 mg capsules once daily

DRUG

Placebo

Two placebo capsules once daily

Trial Locations (1)

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors

collaborator

Case Western Reserve University

OTHER

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University Hospitals Cleveland Medical Center

OTHER

NCT05085834 - Zinc Effect on Inflammation and Cardiovascular Risk in HIV | Biotech Hunter | Biotech Hunter